cost

Access Denied
Operator-Directed Procedural Sedation in the Congenital Cardiac Catheterization Laboratory
Michael L. O’Byrne, Jonathan J. Rome, et al.

JACC: Cardiovascular Interventions
Access Denied
Timing and Causes of Unplanned Readmissions After Percutaneous Coronary InterventionInsights From the Nationwide Readmission Database
Chun Shing Kwok, Mamas Mamas, et al.

JACC: Cardiovascular Interventions
Access Denied
In-Hospital Costs and Costs of Complications of Chronic Total Occlusion AngioplastyInsights From the OPEN-CTO Registry
Adam C. Salisbury, David J. Cohen, et al.

JACC: Cardiovascular Interventions
Access Denied
The Cost of Percutaneous Coronary Intervention for Chronic Total Occlusions in Our Current Cost-Conscious Environment
Gregory J. Dehmer, M. Ayoub Mirza, et al.

JACC: Cardiovascular Interventions
Access Denied
Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and CostInsights From the Nationwide Readmission Database
Chun Shing Kwok, Mamas A. Mamas, et al.

JACC: Cardiovascular Interventions
Access Denied
Comparison of Transfemoral Transcatheter Aortic Valve Replacement Performed in the Catheterization Laboratory (Minimalist Approach) Versus Hybrid Operating Room (Standard Approach)Outcomes and Cost Analysis
Vasilis Babaliaros, Vinod H. Thourani, et al.

JACC: Cardiovascular Interventions
Access Denied
Economic Impact of Same-Day Home Discharge After Uncomplicated Transradial Percutaneous Coronary Intervention and Bolus-Only Abciximab Regimen
Stéphane Rinfret, Olivier F. Bertrand, et al.

JACC: Cardiovascular Interventions

Advertisement